US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Anti-Pandemic Concept

1,839.40

-8.3188-0.45%

Number of Gainers:5

Number of Losers:13

Number of Flat:1

PE:- -

High:1,843.55

Open:1,843.55

Low:1,812.56

Close:1,847.72

Volume:93.66M

Turnover:5.78B

Market Cap:1.50T

Float Cap:1.46T

Loading ...

Berenberg Trims Price Target on AstraZeneca to $203 From $214, Keeps Buy Rating

MT Newswires Live

Abbott’s Volt Pulsed Field Ablation System used for first time in Canada

AstraZeneca's Portfolio Diversity Bodes Well

Berenberg Bank Remains a Buy on AstraZeneca (AZN)

Dow Jones Top Company Headlines at 9 PM ET: OpenAI Buys Startup Developing Smartphone Camera | Abbott ...

Co-Diagnostics EVP Finance and Accounting Daniel Bohrer Files Initial Beneficial Ownership Statement

iBio Highlights Breakthrough Antibody Strategy for Obesity

Novavax Inc. Stock Outperforms Competitors on Strong Trading Day

Inovio Pharmaceuticals Inc. Stock Underperforms Monday When Compared to Competitors

Medtronic PLC Stock Outperforms Competitors on Strong Trading Day

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Abbott Laboratories Stock Outperforms Competitors on Strong Trading Day

Moderna CFO James M. Mock Disposes of 34,836 Common Shares Worth $4.68 Million

Abbott confirms agreement with DOJ to resolve 2022 formula recall claims

AstraZeneca PLC Stock Rises Monday, Outperforms Market

Abbott: no Unopened, Distributed Abbott Infant Formulas Have Ever Tested Positive for Cronobacter Sakazakii

THOMSON REUTERS

Abbott Reaches Agreement with Department of Justice to Resolve Claims Relating to 2022 Infant Formula Recall

THOMSON REUTERS

Abbott - to Pay $385 Mln to Resolve Claims; no Finding of Fault or Liability

THOMSON REUTERS

U.S. Justice Department Says Abbott Agrees to Pay over $384M to Settle Allegations Related to Contaminated Infant Formula

THOMSON REUTERS

AstraZeneca Can Overcome Recent Trial Setbacks

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/BK4568/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"Anti-Pandemic Concept","latestPrice":1839.4017,"timestamp":1789502399999,"preClose":1847.7206,"halted":0,"volume":93656209,"delay":0,"changeRate":-0.004502,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-8.318848,"latestTime":"09-15 16:00:00 EDT","open":1843.5487,"high":1843.552,"low":1812.5594,"amount":5777995351.978435,"amplitude":0.016773,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789565400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.813571,"peRate":46.839236,"turnoverRate":0.006751,"increases":4,"decrements":14,"flats":1,"marketCap":1497269088479,"floatMarketCap":1463142873608},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1843.552,"amplitude":0.016773,"preClose":1847.7206,"low":1812.5594,"pbRate":"4.813571","latestPrice":1839.4017,"volume":93656209,"delay":0,"open":1843.5487,"prevYearClose":1637.1339,"prevWeekClose":1829.725,"prevMonthClose":1860.7577,"prevQuarterClose":1731.2963,"fiveDayClose":1852.4125,"twentyDayClose":1778.7885,"sixtyDayClose":1624.1672,"secType":"PLATE","market":"US","turnoverRate":0.006751,"peRate":46.839236,"marketCap":1497269088479,"floatMarketCap":1463142873608,"timestamp":1789502399999,"nameCN":"Anti-Pandemic Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":5,"down":13,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667649500","title":"Berenberg Trims Price Target on AstraZeneca to $203 From $214, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2667649500","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667649500?lang=en_us&edition=fundamental","pubTime":"2026-09-15 18:42","pubTimestamp":1789468953,"startTime":"0","endTime":"0","summary":"AstraZeneca's (AZN) US stock has an average rating of buy and mean price target of $219.33, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from ma","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AZN","LU0889565916.HKD","LU2417539215.USD","BK4588","LU0320765992.SGD","LU0058720904.USD","LU1267930573.SGD","BK4007","BK4585","LU0708994859.HKD","LU0310800379.SGD","LU0128525929.USD","LU0432979614.USD","LU2089984988.USD","BK4568","LU2236285917.USD","LU2237443382.USD","LU2237443549.SGD","LU1829250122.USD","LU0289739699.SGD","LU0029864427.USD","AZNH","LU2237443978.SGD","LU0109394709.USD","LU2456880835.USD","LU2237443465.HKD","LU2237443622.USD","LU2237443895.HKD","LU2462157665.USD","LU2468319806.SGD","IE00B3T34201.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667973646","title":"Abbott’s Volt Pulsed Field Ablation System used for first time in Canada","url":"https://stock-news.laohu8.com/highlight/detail?id=2667973646","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667973646?lang=en_us&edition=fundamental","pubTime":"2026-09-15 18:15","pubTimestamp":1789467315,"startTime":"0","endTime":"0","summary":"Abbott (ABT) announced that its Volt Pulsed Field Ablation System, designed to deliver more precise, targeted energy with fewer catheter exchanges ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abbotts-volt-pulsed-field-ablation-system-used-for-first-time-in-canada-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abbotts-volt-pulsed-field-ablation-system-used-for-first-time-in-canada-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1914381329.SGD","SGXZ41872573.SGD","LU1057294990.SGD","LU2133065610.SGD","ABT","LU1721429741.USD","LU0882574055.USD","LU1983299246.USD","BK4581","IE0009355771.USD","LU1061106388.HKD","LU2211815571.USD","LU1721429402.USD","IE00B2B36J28.USD","LU0289739699.SGD","BK4592","SG9999002232.USD","LU0170899867.USD","LU1670627923.USD","SG9999004303.SGD","IE00BJJMRZ35.SGD","BK4585","LU0070302665.USD","LU0114720955.EUR","LU1989763427.SGD","LU2237957902.USD","LU0266013472.USD","PJP","IHI","LU0234572021.USD","LU1989763690.USD","IE00BJT1NW94.SGD","LU2237957811.SGD","LU0211331839.USD","SG9999002224.SGD","IE00B4R5TH58.HKD","BK4533","BK4566","SGXZ23171101.USD","LU0432979614.USD","BK4504","LU1670628061.USD","TMED","LU2468319806.SGD","LU1691799644.USD","IE00BFTCPJ56.SGD","IE0002141913.USD","BK4082","BK4588","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667964507","title":"AstraZeneca's Portfolio Diversity Bodes Well","url":"https://stock-news.laohu8.com/highlight/detail?id=2667964507","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667964507?lang=en_us&edition=fundamental","pubTime":"2026-09-15 18:07","pubTimestamp":1789466820,"startTime":"0","endTime":"0","summary":"1007 GMT - AstraZeneca has a robust and diverse portfolio, with strong opportunities in its pipeline, analysts at Berenberg say in a note. The pharmaceutical company is on track to deliver 13% return on research and development investment for its current pipeline cohort, they say. There have been some failures of highly anticipated readouts in 2026, but these were offset by other positive results, highlighting the importance of having a diverse portfolio, they add. Shares are up 2.25% at $163.78.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZNH","BK4588","LU0432979614.USD","LU2468319806.SGD","LU0128525929.USD","LU1267930573.SGD","LU2237443465.HKD","LU2237443622.USD","LU0310800379.SGD","LU0320765992.SGD","LU0289739699.SGD","LU2237443895.HKD","LU2462157665.USD","LU0029864427.USD","BK4568","LU2237443549.SGD","LU2237443978.SGD","LU2089984988.USD","LU1829250122.USD","LU2417539215.USD","BK4585","LU2456880835.USD","LU2237443382.USD","BK4007","LU2236285917.USD","LU0708994859.HKD","LU0058720904.USD","LU0889565916.HKD","IE00B3T34201.USD","LU0109394709.USD","AZN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667199246","title":"Berenberg Bank Remains a Buy on AstraZeneca (AZN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667199246","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667199246?lang=en_us&edition=fundamental","pubTime":"2026-09-15 13:56","pubTimestamp":1789451762,"startTime":"0","endTime":"0","summary":"Berenberg Bank analyst Luisa Hector maintained a Buy rating on AstraZeneca yesterday and set a price target of £150.00. The company’s shares closed...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/berenberg-bank-remains-a-buy-on-astrazeneca-azn-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/berenberg-bank-remains-a-buy-on-astrazeneca-azn-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2236285917.USD","LU0029864427.USD","LU2237443465.HKD","LU2237443622.USD","IE00B3T34201.USD","LU0320765992.SGD","LU0708994859.HKD","BK4588","LU2237443895.HKD","LU1267930573.SGD","LU0289739699.SGD","LU0058720904.USD","BK4007","LU0109394709.USD","LU0128525929.USD","LU2237443978.SGD","BK4568","LU0432979614.USD","LU2089984988.USD","LU2456880835.USD","AZN","LU2468319806.SGD","LU2417539215.USD","LU0310800379.SGD","LU2462157665.USD","AZNH","BK4585","LU0889565916.HKD","LU1829250122.USD","LU2237443549.SGD","LU2237443382.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667692607","title":"Dow Jones Top Company Headlines at 9 PM ET: OpenAI Buys Startup Developing Smartphone Camera | Abbott ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2667692607","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667692607?lang=en_us&edition=fundamental","pubTime":"2026-09-15 09:00","pubTimestamp":1789434000,"startTime":"0","endTime":"0","summary":"OpenAI Buys Startup Developing Smartphone CameraGlass Imaging, valued above $300 million in the deal, was founded by former Apple employees.----Abbott Agrees to $385 Million Settlement in Baby Formula","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABT","LU0122379950.USD","LU0114720955.EUR","BK4581","LU0170899867.USD","LU0289739699.SGD","LU1983299246.USD","DJS","LU1670627923.USD","LU2324357040.USD","IE00BJJMRZ35.SGD","LU2133065610.SGD","BK4533","LU0432979614.USD","LU2089984988.USD","LU0320765489.SGD","SGXZ23171101.USD","LU1670628061.USD","LU2211815571.USD","BK4504","LU0234572021.USD","LU0208291251.USD","LU0882574055.USD","BK4588","LU2112291526.USD","BK4566","LU2468319806.SGD","SG9999002224.SGD","IE00BJT1NW94.SGD","SG9999004303.SGD","LU0211331839.USD","LU0868494617.USD","LU1691799644.USD","IE0002141913.USD","LU0266013472.USD","LU1057294990.SGD","IE00B4R5TH58.HKD","BK4568","LU2237957902.USD","LU1989763427.SGD","LU1061106388.HKD","BK4592","IHI","LU1023059063.AUD","LU1989763690.USD","IE0009355771.USD","LU1721429741.USD","PJP","LU0070302665.USD","TMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667699450","title":"Co-Diagnostics EVP Finance and Accounting Daniel Bohrer Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2667699450","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667699450?lang=en_us&edition=fundamental","pubTime":"2026-09-15 06:50","pubTimestamp":1789426209,"startTime":"0","endTime":"0","summary":"Co-Diagnostics EVP Finance and Accounting Daniel Bohrer files initial beneficial ownership statementCo-Diagnostics EVP of Finance & Accounting Daniel Bohrer filed an initial Form 3 reporting 3,657 com","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nNDLc90YYm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4568","CODX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667696746","title":"iBio Highlights Breakthrough Antibody Strategy for Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2667696746","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667696746?lang=en_us&edition=fundamental","pubTime":"2026-09-15 05:53","pubTimestamp":1789422816,"startTime":"0","endTime":"0","summary":"An announcement from Ibio ( ($IBIO) ) is now available. In September 2026, iBio updated its corporate presentation to highlight a strategic focus o...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ibio-highlights-breakthrough-antibody-strategy-for-obesity?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ibio-highlights-breakthrough-antibody-strategy-for-obesity?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBIO","BK4568","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667969736","title":"Novavax Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2667969736","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667969736?lang=en_us&edition=fundamental","pubTime":"2026-09-15 05:29","pubTimestamp":1789421340,"startTime":"0","endTime":"0","summary":"DJ Novavax Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Novavax Inc.  rallied 1.80% to $9.59 Monday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index  falling 0.56% to 26,186.41 and Dow Jones Industrial Average  falling 0.29% to 52,421.20.This was the stock's second consecutive day of gains.Novavax Inc. closed 19.88% short of its 52-week high of $11.97, which the company reached on February 26th.The stock outperformed some of its competitors Monday, as Johnson & Johnson  rose 0.28% to $266.32, Pfizer Inc.  remained unchanged, and Merck & Co. Inc.  rose 0.64% to $144.85.Trading volume  remained 881,146 below its 50-day average volume of 4.2 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 14, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4547","BK4568","BK4585","NVAX","BK4588","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667696961","title":"Inovio Pharmaceuticals Inc. Stock Underperforms Monday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2667696961","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667696961?lang=en_us&edition=fundamental","pubTime":"2026-09-15 05:25","pubTimestamp":1789421100,"startTime":"0","endTime":"0","summary":"DJ Inovio Pharmaceuticals Inc. Stock Underperforms Monday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Inovio Pharmaceuticals Inc.  slid 5.60% to $1.18 Monday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index  falling 0.56% to 26,186.41 and Dow Jones Industrial Average  falling 0.29% to 52,421.20.This was the stock's fifth consecutive day of losses.Inovio Pharmaceuticals Inc. closed 56.62% below its 52-week high of $2.72, which the company reached on December 17th.The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson  rose 0.28% to $266.32, Statera Biopharma Inc.  remained unchanged, and Pfizer Inc.  remained unchanged.Trading volume  remained 803,447 below its 50-day average volume of 4.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 14, 2026.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4583","INO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667457695","title":"Medtronic PLC Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2667457695","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667457695?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:38","pubTimestamp":1789418280,"startTime":"0","endTime":"0","summary":"DJ Medtronic PLC Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Medtronic PLC  advanced 3.12% to $93.80 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.48% to 7,619.98 and Dow Jones Industrial Average  falling 0.29% to 52,421.20.The stock's rise snapped a four-day losing streak.Medtronic PLC closed 11.78% below its 52-week high of $106.33, which the company reached on November 26th.The stock outperformed some of its competitors Monday, as Johnson & Johnson  rose 0.28% to $266.32, Danaher Corp.  rose 1.55% to $203.25, and Abbott Laboratories  rose 1.12% to $103.09.Trading volume  eclipsed its 50-day average volume of 7.5 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 14, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DHR","IE0000B7K699.USD","LU0053666078.USD","LU0203347892.USD","LU0106261372.USD","FMED","RXL","LU0109391861.USD","LU1989764664.SGD","JNJ","LU0320765489.SGD","LU0289961442.SGD","LU2456880835.USD","VHT","IE0002141913.USD","LU0069063385.USD","IYH","SG9999001440.SGD","LU2023250504.SGD","LU1935042991.SGD","BK4568","LU2468319806.SGD","MEDX","LU2265009873.SGD","BK4532","ABT","FTXH","PJP","XLV","LU0472753341.HKD","GDOC","JDOC","LU2089984988.USD","MDT","IXJ","IE00BGHQF631.EUR","IE00B42XCP33.USD","LU0098860793.USD","LU0496365809.HKD","LU2111349929.HKD","IHI","LU2028103732.USD","TMED","TRUH","IHE","FHLC","IE000BZT7R73.USD","LU1721429402.USD","LU0234572021.USD","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667695453","title":"Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2667695453","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667695453?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:36","pubTimestamp":1789418160,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  rallied 1.87% to $146.41 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.48% to 7,619.98 and Dow Jones Industrial Average  falling 0.29% to 52,421.20.The stock's rise snapped a five-day losing streak.Gilead Sciences Inc. closed 6.92% below its 52-week high of $157.29, which the company achieved on February 11th.The stock outperformed some of its competitors Monday, as Johnson & Johnson  rose 0.28% to $266.32, Pfizer Inc.  remained unchanged, and Abbott Laboratories  rose 1.12% to $103.09.Trading volume  remained 1.5 million below its 50-day average volume of 6.3 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 14, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1674673428.USD","LU1066053197.SGD","IE00B19Z3581.USD","LU0861579265.USD","LU1571399168.USD","LU1674673691.USD","SG9999015952.SGD","LU1430594728.SGD","IE00B7SZLL34.SGD","MEDI","IE00BSNM7G36.USD","LU1839511570.USD","IBBQ","TMED","LU1778281490.HKD","BK4583","IE00B19Z3B42.SGD","BBH","LU2468319806.SGD","TBXU","LU1057294990.SGD","IE00BZ1G4Q59.USD","LU0965509101.SGD","LU1061106388.HKD","LU1066051498.USD","LU0320765992.SGD","IBB","LU1037948541.HKD","BK4578","LU2112291526.USD","LU0058720904.USD","SG9999015978.USD","IE00BKVL7J92.USD","BK4566","BMED","LU0965508806.USD","LU0965509283.SGD","LU1023059063.AUD","LU1585245621.USD","LU1934455194.USD","LU0114720955.EUR","BIB","LU0859254822.USD","LU0889565916.HKD","LU0882574055.USD","BK4585","LU0965509010.AUD","BK4550","LU2089984988.USD","LU0122379950.USD","BK4139","BK4568","IE00B3T34201.USD","LU0109394709.USD","LU0234570918.USD","SG9999015986.USD","LU2357627491.SGD","LU1934455277.USD","LU1037948897.HKD","LU0289739699.SGD","LU2087621335.USD","LU1934455863.HKD","BK4532","LU2324357040.USD","LU0823416689.USD","IE0002270589.USD","GILD","SG9999015945.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667139695","title":"Abbott Laboratories Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2667139695","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667139695?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:36","pubTimestamp":1789418160,"startTime":"0","endTime":"0","summary":"DJ Abbott Laboratories Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Abbott Laboratories  rallied 1.12% to $103.09 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.48% to 7,619.98 and Dow Jones Industrial Average  falling 0.29% to 52,421.20.The stock's rise snapped a six-day losing streak.Abbott Laboratories closed 25.02% below its 52-week high of $137.49, which the company reached on September 22nd.The stock outperformed some of its competitors Monday, as Johnson & Johnson  rose 0.28% to $266.32, Pfizer Inc.  remained unchanged, and Merck & Co. Inc.  rose 0.64% to $144.85.Trading volume  remained 2.0 million below its 50-day average volume of 9.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 14, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","ABT","IE00B2B36J28.USD","SG9999002224.SGD","LU0058720904.USD","BK4588","LU0868494617.USD","IE00B4R5TH58.HKD","LU0114720955.EUR","LU0211331839.USD","BK4581","LU0122379950.USD","IE0002141913.USD","IE0009355771.USD","IE00BJT1NW94.SGD","LU0320765489.SGD","LU1989763427.SGD","BK4082","LU1721429402.USD","SGXZ23171101.USD","LU0432979614.USD","LU1914381329.SGD","TMED","LU0289739699.SGD","IE00BJJMRZ35.SGD","LU2468319806.SGD","LU1670627923.USD","BK4592","LU0070302665.USD","IE00BFTCPJ56.SGD","LU0266013472.USD","LU2237957902.USD","LU2112291526.USD","LU0208291251.USD","LU1983299246.USD","LU2324357040.USD","PJP","LU0170899867.USD","LU1721429741.USD","SGXZ41872573.SGD","IHI","LU1670628061.USD","LU1023059063.AUD","BK4566","LU1989763690.USD","LU0234572021.USD","LU2089984988.USD","SG9999002232.USD","LU1061106388.HKD","BK4504","LU2211815571.USD","LU0882574055.USD","LU2237957811.SGD","LU1057294990.SGD","SG9999004303.SGD","BK4568","LU1691799644.USD","BK4585","LU2133065610.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667695518","title":"Moderna CFO James M. Mock Disposes of 34,836 Common Shares Worth $4.68 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2667695518","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667695518?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:25","pubTimestamp":1789417559,"startTime":"0","endTime":"0","summary":"Moderna CFO James M. Mock disposes of 34,836 common shares worth $4.68 millionModerna CFO Mock James M disclosed sales of 34,836 common shares on Sep. 10, 2026 at USD 134.49.He also exercised stock op","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nNDL8rXTDg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Moderna CFO James M. Mock Disposes of 34,836 Common Shares Worth $4.68 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","BK4588","MRNY","MRNA","IDNA","BK4534","BK4533","BK4568","BK4585","LGHT","MRNX","BK4532","WDNA","GNOM","BK4501","BK4548","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667667304","title":"Abbott confirms agreement with DOJ to resolve 2022 formula recall claims","url":"https://stock-news.laohu8.com/highlight/detail?id=2667667304","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667667304?lang=en_us&edition=fundamental","pubTime":"2026-09-15 00:00","pubTimestamp":1789401623,"startTime":"0","endTime":"0","summary":"Abbott (ABT) confirmed the company has reached an agreement to resolve the previously disclosed investigation and lawsuit brought by the United Sta...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abbott-confirms-agreement-with-doj-to-resolve-2022-formula-recall-claims-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abbott-confirms-agreement-with-doj-to-resolve-2022-formula-recall-claims-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TMED","BK4504","IE00BFTCPJ56.SGD","LU1691799644.USD","BK4568","BK4592","LU1914381329.SGD","LU2089984988.USD","SGXZ23171101.USD","LU1989763427.SGD","BK4585","LU1721429741.USD","BK4566","LU0289739699.SGD","LU0868494617.USD","BK4533","LU2133065610.SGD","LU2237957811.SGD","SG9999002232.USD","SG9999002224.SGD","LU0122379950.USD","PJP","BK4082","LU1721429402.USD","LU0070302665.USD","LU2468319806.SGD","LU0432979614.USD","LU1057294990.SGD","IE00B4R5TH58.HKD","LU0058720904.USD","IE00BJJMRZ35.SGD","BK4581","IHI","LU1670628061.USD","IE0002141913.USD","LU0266013472.USD","LU1983299246.USD","LU0320765489.SGD","LU0208291251.USD","LU2237957902.USD","IE00B2B36J28.USD","LU1670627923.USD","LU0114720955.EUR","LU0170899867.USD","LU0882574055.USD","ABT","IE00BJT1NW94.SGD","LU1989763690.USD","SG9999004303.SGD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667667566","title":"AstraZeneca PLC Stock Rises Monday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2667667566","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667667566?lang=en_us&edition=fundamental","pubTime":"2026-09-15 00:00","pubTimestamp":1789401600,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of AstraZeneca PLC rose 3.5% to SEK1,592.00 Monday on what proved to be an overall poor trading session for the stock market, with the OMX Nordic 40 Index falling 1.6% to 2,615.34.The company closed SEK333.50 below its 52-week high of SEK1,925.50, which the company achieved on April 10, 2026.Trading volume was 953,134, compared to the 50-day average trading volume of 614,374.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2468319806.SGD","LU2237443382.USD","LU2089984988.USD","LU1829250122.USD","LU2237443978.SGD","LU0029864427.USD","AZN","LU2236285917.USD","LU1267930573.SGD","LU2456880835.USD","AZNH","LU0058720904.USD","LU2237443465.HKD","IE00B3T34201.USD","LU0320765992.SGD","LU0432979614.USD","LU0109394709.USD","LU0310800379.SGD","LU2417539215.USD","LU2462157665.USD","BK4588","LU0128525929.USD","LU2237443895.HKD","BK4007","LU0289739699.SGD","LU0889565916.HKD","LU2237443622.USD","BK4585","BK4568","LU2237443549.SGD","LU0708994859.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667766207","title":"Abbott: no Unopened, Distributed Abbott Infant Formulas Have Ever Tested Positive for Cronobacter Sakazakii","url":"https://stock-news.laohu8.com/highlight/detail?id=2667766207","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667766207?lang=en_us&edition=fundamental","pubTime":"2026-09-14 23:52","pubTimestamp":1789401174,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUAC4MDDB:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1721429402.USD","LU0882574055.USD","LU0266013472.USD","IE00BFTCPJ56.SGD","LU0058720904.USD","LU2468319806.SGD","PJP","IE00BJT1NW94.SGD","LU1670627923.USD","LU1914381329.SGD","SG9999004303.SGD","IE00BJJMRZ35.SGD","LU1057294990.SGD","SGXZ23171101.USD","LU0868494617.USD","BK4568","IE0002141913.USD","IE0009355771.USD","IE00B4R5TH58.HKD","SG9999002224.SGD","LU1989763690.USD","BK4504","LU2237957902.USD","LU0070302665.USD","LU2133065610.SGD","LU2237957811.SGD","LU0170899867.USD","LU0208291251.USD","BK4592","IE00B2B36J28.USD","LU0320765489.SGD","LU1989763427.SGD","BK4581","BK4082","LU1670628061.USD","LU1721429741.USD","TMED","LU0289739699.SGD","BK4585","BK4533","ABT","LU0122379950.USD","LU0114720955.EUR","SG9999002232.USD","LU1691799644.USD","LU0432979614.USD","LU1983299246.USD","IHI","BK4566","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667662076","title":"Abbott Reaches Agreement with Department of Justice to Resolve Claims Relating to 2022 Infant Formula Recall","url":"https://stock-news.laohu8.com/highlight/detail?id=2667662076","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667662076?lang=en_us&edition=fundamental","pubTime":"2026-09-14 23:52","pubTimestamp":1789401174,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUAC4MDDB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0009355771.USD","LU0320765489.SGD","BK4533","BK4504","LU2133065610.SGD","IE00BJJMRZ35.SGD","SGXZ41872573.SGD","IE00B4R5TH58.HKD","LU0266013472.USD","BK4585","PJP","IE00BFTCPJ56.SGD","BK4588","LU0882574055.USD","LU2237957902.USD","LU0114720955.EUR","LU0868494617.USD","LU1061106388.HKD","BK4568","LU0234572021.USD","LU1721429402.USD","LU1983299246.USD","SG9999002232.USD","LU0122379950.USD","LU0432979614.USD","LU0289739699.SGD","BK4581","LU1023059063.AUD","LU1989763427.SGD","LU1721429741.USD","LU1914381329.SGD","LU0208291251.USD","SGXZ23171101.USD","TMED","LU2324357040.USD","IHI","SG9999002224.SGD","LU0211331839.USD","LU0058720904.USD","LU1670628061.USD","LU1670627923.USD","BK4592","BK4082","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU2089984988.USD","ABT","BK4566","LU0070302665.USD","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667366200","title":"Abbott - to Pay $385 Mln to Resolve Claims; no Finding of Fault or Liability","url":"https://stock-news.laohu8.com/highlight/detail?id=2667366200","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667366200?lang=en_us&edition=fundamental","pubTime":"2026-09-14 23:52","pubTimestamp":1789401174,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUAC4MDDB:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2133065610.SGD","BK4082","LU0432979614.USD","LU1057294990.SGD","LU1721429402.USD","LU1670627923.USD","IE00B2B36J28.USD","LU1061106388.HKD","LU2211815571.USD","IE00BJT1NW94.SGD","LU1989763427.SGD","BK4592","LU2089984988.USD","SG9999002232.USD","ABT","LU0266013472.USD","LU1989763690.USD","LU2468319806.SGD","LU0170899867.USD","LU2112291526.USD","LU0320765489.SGD","BK4585","PJP","BK4568","LU1983299246.USD","LU0289739699.SGD","SG9999004303.SGD","LU0058720904.USD","BK4566","IE0002141913.USD","IE00B4R5TH58.HKD","LU1721429741.USD","SGXZ41872573.SGD","LU0234572021.USD","BK4533","BK4581","TMED","IHI","LU1914381329.SGD","LU2237957902.USD","BK4588","BK4504","LU2237957811.SGD","LU2324357040.USD","SG9999002224.SGD","LU0122379950.USD","LU0882574055.USD","LU0114720955.EUR","LU0070302665.USD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667866209","title":"U.S. Justice Department Says Abbott Agrees to Pay over $384M to Settle Allegations Related to Contaminated Infant Formula","url":"https://stock-news.laohu8.com/highlight/detail?id=2667866209","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667866209?lang=en_us&edition=fundamental","pubTime":"2026-09-14 23:48","pubTimestamp":1789400907,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nFWN4560EN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PJP","LU0234572021.USD","IE0009355771.USD","BK4592","LU0320765489.SGD","LU0868494617.USD","LU1057294990.SGD","LU2237957902.USD","LU0211331839.USD","LU1989763690.USD","LU2112291526.USD","SG9999004303.SGD","LU2237957811.SGD","LU1721429402.USD","LU2089984988.USD","LU0208291251.USD","LU1691799644.USD","SGXZ41872573.SGD","BK4566","LU1670627923.USD","LU1983299246.USD","LU0114720955.EUR","LU2468319806.SGD","ABT","LU0070302665.USD","TMED","BK4581","BK4568","IE00B4R5TH58.HKD","LU2133065610.SGD","IE00BJT1NW94.SGD","LU0882574055.USD","LU2211815571.USD","LU0122379950.USD","LU0289739699.SGD","BK4082","LU0058720904.USD","IHI","LU1061106388.HKD","SG9999002232.USD","LU1721429741.USD","LU1023059063.AUD","BK4533","BK4585","BK4588","SG9999002224.SGD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","IE0002141913.USD","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667623806","title":"AstraZeneca Can Overcome Recent Trial Setbacks","url":"https://stock-news.laohu8.com/highlight/detail?id=2667623806","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667623806?lang=en_us&edition=fundamental","pubTime":"2026-09-14 23:04","pubTimestamp":1789398240,"startTime":"0","endTime":"0","summary":"1504 GMT - AstraZeneca just suffered its third failure of a late-stage clinical trial in less than three months, but it can overcome these setbacks, Bernstein analysts say in a research note. The negative results of its Etcamah breast-cancer drug add to earlier disappointing results for its Wainua drug in a heart-disease trial and for lung-cancer drug candidate volrustomig.Swiss rival Roche was also hit by three late-stage trial failures in 2022 and its stock underperformed European peers until the fourth quarter of 2025, but AstraZeneca doesn't have to follow the same fate, Bernstein says. AstraZeneca's late-stage drug pipeline looks fuller than Roche's was back then, and the majority of its studies with results due next year should face low risk, the analysts say. AstraZeneca shares rise 3.1%.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2456880835.USD","LU0432979614.USD","LU2462157665.USD","LU2236285917.USD","LU0889565916.HKD","LU1829250122.USD","LU0128525929.USD","LU0289739699.SGD","BK4568","LU2089984988.USD","LU0708994859.HKD","LU2237443382.USD","AZN","LU2237443549.SGD","LU2237443895.HKD","LU0109394709.USD","AZNH","IE00B3T34201.USD","LU0320765992.SGD","LU2237443465.HKD","BK4585","LU2417539215.USD","LU0058720904.USD","LU0310800379.SGD","LU2468319806.SGD","LU0029864427.USD","LU1267930573.SGD","BK4588","BK4007","LU2237443622.USD","LU2237443978.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":11,"pageCount":2,"totalSize":212,"code":"91000000","status":"200"}]}}